The rAb products of these NMO patient-derived plasmablasts have reproduced CNS tissue pathology in multiple models of NMO lesion pathogenesis (3, 5, 20) demonstrating their ability to reproduce the pathogenicity of serum NMO-IgG. This evidence concerns the gene AGFG1 and neuromyelitis optica.